Arca Biopharma | ABIO - أسهم رأس المال العادية





أسهم رأس المال العادية تغيير تاريخ
Alterity Therapeutics Limited AUD 10.88B 10.66B 2025-12
Amgen USD 541M 0 2026-09
Arca Biopharma USD 50.17M 1.45M 2026-03
Biogen USD 146.7M 200K 2025-09
Brainstorm Cell Therapeutics USD 11.04M 0 2026-03
Bristol-Myers Squibb USD 2.04B 7M 2026-06
Capricor Therapeutics USD 57.37M 11.65M 2025-12
Cipla INR 807.87M 88K 2026-09
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 94.72M 170K 2026-06
CSL USD 482.13M 93.87M 2025-12
Cytokinetics USD 138.76M 14.33M 2026-06
Daiichi Sankyo JPY 1.82B 1.68M 2026-09
Gilead Sciences USD 1.24B 1000K 2026-06
GlaxoSmithKline GBP 2.02B 2.05B 2026-09
Grifols EUR 680.58M 846.11K 2025-12
Laboratory Of America USD 81.2M 300K 2026-09
Myriad Genetics USD 93.5M 400K 2025-12
Otsuka Holdings JPY 523.91M 1.48M 2026-09
Pfizer USD 5.7B 1000K 2026-09
United Therapeutics USD 42.38M 295K 2026-09